Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite

British Journal of Pharmacology

Volumn 169, Issue 3, 2013, Pages 659-670

  Maher, Abdul R ^a   Arif, Sayqa ^a   Madhani, Melanie ^a   Abozguia, Khalid ^a   Ahmed, Ibrar ^a   Fernandez, Bernadette O ^b   Feelisch, Martin ^b   O'Sullivan, A G ^a   Christopoulos, Arthur ^c   Sverdlov, Aaron L ^d   Ngo, Doan ^d   Dautov, Rustem ^d   James, Philip E ^e   Horowitz, John D ^d   Frenneaux, Michael P ^f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

heart failure; sodium nitrite; vascular effects

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; NITRIC OXIDE; NITRITE; OXYGEN; PERHEXILINE; PLASMA PROTEIN; WARFARIN;

ADULT; ARTICLE; BLOOD PH; BLOOD VOLUME; BRACHIAL ARTERY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INFUSION; DRUG TOLERABILITY; FEMALE; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFUSION RATE; LONG TERM EXPOSURE; MALE; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PRIORITY JOURNAL; VASOMOTOR REFLEX; VEIN DILATATION;

AGED; BRACHIAL ARTERY; COHORT STUDIES; DRUG TOLERANCE; FEMALE; FOREARM; HEART FAILURE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; OXIDATIVE STRESS; REGIONAL BLOOD FLOW; SAPHENOUS VEIN; SODIUM NITRITE; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 84877820465     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12152     Document Type: Article

References (42)

1. Anderson RA, Ellis GR, Chirkov YY, Holmes AS, Payne N, Blackman DJ, et al. (2004). Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure. Eur J Heart Fail 6: 47-54.
2. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, et al. (1997). Diastolic ventricular interaction in chronic heart failure. Lancet 349: 1720-1724.
3. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, et al. (2007). Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 43: 437-444.
4. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D, (1995). Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25: 918-923.
5. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, et al. (2005). Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 1: 290-297.
6. Chen Z, Zhang J, Stamler JS, (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 99: 8306-8311.
7. Chirkov YY, Horowitz JD, (2007). Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier? Pharmacol Ther 116: 287-305.
8. Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD, (1999). Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 100: 129-134.
9. Chirkov YY, Holmes AS, Willoughby SR, Stewart S, Wuttke RD, Sage PR, et al. (2001). Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 37: 1851-1857.
10. Chirkov YY, Holmes AS, Martelli JD, Horowitz JD, (2004). Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction. Am J Cardiol 93: 1438-1440, A10.
11. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. (2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505.
12. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. (1998). Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351: 389-393.
13. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, et al. (2006). Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107: 566-574.
14. D'Souza Y, Dowlatshahi S, Bennett BM, (2011). Changes in aldehyde dehydrogenase 2 expression in rat blood vessels during glyceryl trinitrate tolerance development and reversal. Br J Pharmacol 164: 632-643.
15. Daiber A, Mulsch A, Hink U, Mollnau H, Warnholtz A, Oelze M, et al. (2005). The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine. Am J Cardiol 96: 25i-36i.
16. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, et al. (2007). Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116: 1821-1831.
17. Dupuis J, Lalonde G, Lebeau R, Bichet D, Rouleau JL, (1990). Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J 120: 625-637.
18. Feelisch M, Fernandez BO, Bryan NS, Garcia-Saura MF, Bauer S, Whitlock DR, et al. (2008). Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J Biol Chem 283: 33927-33934.
19. Gunaruwan P, Schmitt M, Taylor J, Lee L, Struthers A, Frenneaux MP, (2002). Lack of rapid aldosterone effects on forearm resistance vasculature in health. J Renin Angiotensin Aldosterone Syst 3: 123-125.
20. Heiss C, Lauer T, Dejam A, Kleinbongard P, Hamada S, Rassaf T, et al. (2006). Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol 47: 573-579.
21. Henry PJ, Horowitz JD, Louis WJ, (1990). Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. J Cardiovasc Pharmacol 15: 365-370.
22. Ingram TE, Pinder AG, Bailey DM, Fraser AG, James PE, (2010). Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol 298: H331-H339.
23. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, et al. (2003). Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35: 790-796.
24. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, et al. (2001). Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A 98: 12814-12819.
25. Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, et al. (2005). Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol 25: 1891-1895.
26. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, et al. (2008). Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 117: 670-677.
27. Manyari DE, Wang Z, Cohen J, Tyberg JV, (1993). Assessment of the human splanchnic venous volume-pressure relation using radionuclide plethysmography. Effect of nitroglycerin. Circulation 87: 1142-1151.
28. Milsom AB, Patel NS, Mazzon E, Tripatara P, Storey A, Mota-Filipe H, et al. (2010). Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Nitric Oxide 22: 141-148.
29. Muir AL, Nolan J, (1991). Modulation of venous tone in heart failure. Am Heart J 121 (6 Pt 2): 1948-1950.
30. Munzel T, Daiber A, Mulsch A, (2005). Explaining the phenomenon of nitrate tolerance. Circ Res 97: 618-628.
31. Ng ES, Jourd'heuil D, McCord JM, Hernandez D, Yasui M, Knight D, et al. (2004). Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 94: 559-565.
32. Pinder AG, Rogers SC, Khalatbari A, Ingram TE, James PE, (2009). The measurement of nitric oxide and its metabolites in biological samples by ozone-based chemiluminescence. Methods Mol Biol 476: 10-27.
33. Rassaf T, Bryan NS, Kelm M, Feelisch M, (2002). Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med 33: 1590-1596.
34. Sage PR, de la Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, et al. (2000). Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 102: 2810-2815.
35. Schmitt M, Blackman DJ, Middleton GW, Cockcroft JR, Frenneaux MP, (2002). Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications. Br J Clin Pharmacol 54: 565-576.
36. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, et al. (2000). High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 36: 832-837.
37. Shiva S, Gladwin MT, (2009). Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104: 113-119.
38. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, et al. (2007). Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100: 654-661.
39. Towell JF, Barboriak JJ, Townsend WF, Kalbfleisch JH, Wang RI, (1986). Erythrocyte aldehyde dehydrogenase: assay of a potential biochemical marker of alcohol abuse. Clin Chem 32: 734-738.
40. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T, (1998). Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62: 2425-2430.
41. Webb AJ, Milsom AB, Rathod KS, Chu WL, Qureshi S, Lovell MJ, et al. (2008). Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ Res 103: 957-964.
42. Williams L, Frenneaux MP, (2006). Diastolic ventricular interaction: from physiology to clinical practice. Nat Clin Pract Cardiovasc Med 3: 368-376.